{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:54:41Z","timestamp":1793332481500,"version":"4.5.0"},"reference-count":28,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T00:00:00Z","timestamp":1745452800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Budesonide, an inhaled corticosteroid, and surfactant, a substance that lowers surface tension in the lungs, are both used to prevent Bronchopulmonary Dysplasia (BPD). This meta-analysis evaluates the effectiveness of combining budesonide and surfactant in preventing BPD in preterm neonates compared to surfactant alone.<\/jats:p><\/jats:sec><jats:sec><jats:title>Method<\/jats:title><jats:p>A comprehensive search of electronic databases, including PubMed, Scopus, Google Scholar, CNKI, and Embase, was conducted from their inception up to August 30, 2024. The focus was on evaluating the combination of Budesonide and surfactant for the prevention of BPD in preterm neonates. This assessment involved calculating ORs and their 95% CIs to determine the treatment's effectiveness. The primary outcomes measured were the incidence of BPD and mortality rates, while secondary outcomes included the rates of intraventricular hemorrhage (IVH), retinopathy of prematurity (ROP), patent ductus arteriosus (PDA), sepsis, neonatal necrotizing enterocolitis (NEC), and pneumothorax.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>This research, combining a meta-analysis and observational data, indicates that Budesonide-Surfactant therapy significantly reduces BPD in preterm neonates with NRDS, regardless of gestational age. Additional benefits, including decreased mortality (in \u226527 gestational weeks), NEC, PDA, ROP, and Sepsis, were observed in the observational study, though pneumothorax increased in the \u226527 gestational weeks group. The meta-analysis corroborated reductions in BPD, PDA, and mortality (in \u226527 gestational weeks), supporting the potential of Budesonide-Surfactant to improve outcomes in preterm infants.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The intratracheal administration of pulmonary surfactants combined with budesonide was associated with a reduction in the incidence of BPD, mortality, and PDA. Although the prevalence of ROP, NEC, IVH, and sepsis was lower in the test group compared to the control group, these differences did not reach statistical significance. These findings suggest that the combined use of budesonide and surfactant is effective in preventing BPD and mortality, as well as in reducing certain secondary outcomes.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fped.2025.1518957","type":"journal-article","created":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T05:30:16Z","timestamp":1745472616000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Meta-analysis of budesonide and surfactant combination for the prevention of bronchopulmonary dysplasia in preterm neonates based on gestational age"],"prefix":"10.3389","volume":"13","author":[{"given":"Sedigheh","family":"Ekraminasab","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmood","family":"Noorishadkam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Neamatzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad Hosein","family":"Lookzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Reza","family":"Mirjalili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahta","family":"Mazaheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyedeh Elham","family":"Shams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,4,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3390\/jcm6010004","article-title":"Bronchopulmonary dysplasia: chronic lung disease of infancy and long-term pulmonary outcomes","volume":"6","author":"Davidson","year":"2017","journal-title":"J Clin Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s40348-021-00129-5","article-title":"Patho-mechanisms of the origins of bronchopulmonary dysplasia","volume":"8","author":"Sahni","year":"2021","journal-title":"Mol Cell Pediatr"},{"key":"B3","doi-asserted-by":"publisher","first-page":"70","DOI":"10.3390\/medsci11040070","article-title":"Alveolar hyperoxia and exacerbation of lung injury in critically ill SARS-CoV-2 pneumonia","volume":"11","author":"Dushianthan","year":"2023","journal-title":"Med Sci"},{"key":"B4","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1002\/bdra.23235","article-title":"Epidemiology of bronchopulmonary dysplasia","volume":"100","author":"Jensen","year":"2014","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/s41390-018-0167-9","article-title":"The definition of bronchopulmonary dysplasia: an evolving dilemma","volume":"84","author":"Ibrahim","year":"2018","journal-title":"Pediatr Res"},{"key":"B6","doi-asserted-by":"publisher","first-page":"e211","DOI":"10.1542\/neo.19-4-e211","article-title":"Health care and societal costs of bronchopulmonary dysplasia","volume":"19","author":"Lapcharoensap","year":"2018","journal-title":"Neoreviews"},{"key":"B7","doi-asserted-by":"publisher","first-page":"72","DOI":"10.18332\/tid\/156854","article-title":"Active or passive maternal smoking increases the risk of low birth weight or preterm delivery: benefits of cessation and tobacco control policies","volume":"21","author":"Delcroix","year":"2023","journal-title":"Tob Induc Dis"},{"key":"B8","doi-asserted-by":"publisher","first-page":"132","DOI":"10.3390\/children8020132","article-title":"Non-invasive ventilatory strategies to decrease bronchopulmonary dysplasia-where are we in 2021?","volume":"8","author":"Dumpa","year":"2021","journal-title":"Children (Basel)"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.3892\/etm.2017.4694","article-title":"Inhaled corticosteroids improve lung function, airway hyper-responsiveness and airway inflammation but not symptom control in patients with mild intermittent asthma: a meta-analysis","volume":"14","author":"Du","year":"2017","journal-title":"Exp Ther Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"81","DOI":"10.5409\/wjcp.v4.i4.81","article-title":"Caffeine therapy in preterm infants","volume":"4","author":"Abdel-Hady","year":"2015","journal-title":"World J Clin Pediatr"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1439265","DOI":"10.3389\/fped.2024.1439265","article-title":"Strategies for the prevention of bronchopulmonary dysplasia","volume":"12","author":"Dini","year":"2024","journal-title":"Front Pediatr"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e289","DOI":"10.5001\/omj.2021.84","article-title":"A randomized clinical trial of intratracheal administration of surfactant and budesonide combination in comparison to surfactant for prevention of bronchopulmonary dysplasia","volume":"36","author":"Gharehbaghi","year":"2021","journal-title":"Oman Med J"},{"key":"B13","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jped.2022.10.007","article-title":"Use of budesonide associated with a pulmonary surfactant to prevent bronchopulmonary dysplasia in premature newborns\u2014a systematic review","volume":"99","author":"Moraes","year":"2023","journal-title":"J Pediatr"},{"key":"B14","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1002\/ppul.23680","article-title":"Intratracheal administration of budesonide-surfactant in prevention of bronchopulmonary dysplasia in very low birth weight infants: a systematic review and meta-analysis","volume":"52","author":"Venkataraman","year":"2017","journal-title":"Pediatr Pulmonol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.22038\/ijn.2023.72572.2406","article-title":"Intratracheal administration of budesonide-instilled surfactant for prevention of bronchopulmonary dysplasia: a randomized controlled clinical trial","volume":"14","author":"Armanian","year":"2023","journal-title":"Iran J Neonatol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"439","DOI":"10.3390\/healthcare11030439","article-title":"Early surfactant therapy for respiratory distress syndrome in very preterm infants","volume":"11","author":"Cucerea","year":"2023","journal-title":"Healthcare (Basel)"},{"key":"B17","doi-asserted-by":"publisher","first-page":"526","DOI":"10.21037\/tp-22-8","article-title":"A systematic review and meta-analysis of pulmonary surfactant combined with budesonide in the treatment of neonatal respiratory distress syndrome","volume":"11","author":"Yi","year":"2022","journal-title":"Transl Pediatr"},{"key":"B18","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1164\/rccm.201505-0861OC","article-title":"Intratracheal administration of budesonide\/surfactant to prevent bronchopulmonary dysplasia","volume":"193","author":"Yeh","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"B19","doi-asserted-by":"publisher","first-page":"551","DOI":"10.24953\/turkjped.2020.04.004","article-title":"Intratracheal administration of budesonide with surfactant in very low birth weight infants to prevent bronchopulmonary dysplasia","volume":"62","author":"Heo","year":"2020","journal-title":"Turk J Pediatr"},{"key":"B20","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1002\/ppul.25415","article-title":"Intra-tracheal surfactant\/budesonide versus surfactant alone: comparison of two consecutive cohorts of extremely preterm infants","volume":"56","author":"Moschino","year":"2021","journal-title":"Pediatr Pulmonol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"135","DOI":"10.4103\/jcn.jcn_52_23","article-title":"Budesonide and surfactant combination for treatment of respiratory distress syndrome in preterm neonates and evaluation outcomes","volume":"12","author":"BaghalSafa","year":"2023","journal-title":"J Clin Neonatol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1186\/s12887-024-04736-9","article-title":"The impact of combined administration of surfactant and intratracheal budesonide compared to surfactant alone on bronchopulmonary dysplasia (BPD) and mortality rate in preterm infants with respiratory distress syndrome: a single-blind randomized clinical","volume":"24","author":"Marzban","year":"2024","journal-title":"BMC Pediatr"},{"key":"B23","doi-asserted-by":"publisher","first-page":"48","DOI":"10.61186\/sjku.28.6.48","article-title":"Comparison of the consequences of intratracheal administration of surfactant plus budesonide with surfactant alone in preterm infants with respiratory distress syndrome","volume":"28","author":"Habibi","year":"2024","journal-title":"Sci J Kurdistan Univ Med Sci"},{"key":"B24","first-page":"304","article-title":"Simultaneous intratracheal administration of surfactant and budesonide in the prevention of bronchopulmonary dysplasia in the treatment of respiratory distress syndrome in premature infants","volume":"10","author":"Kashaki","year":"2023","journal-title":"Adv Life Sci"},{"key":"B25","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1038\/s41390-019-0663-6","article-title":"Surfactant and budesonide for respiratory distress syndrome: an observational study","volume":"87","author":"Kothe","year":"2020","journal-title":"Pediatr Res"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1038\/s41372-021-01066-x","article-title":"Budesonide mixed with surfactant did not affect neurodevelopmental outcomes at 6 or 18 months corrected age in observational cohorts","volume":"41","author":"Anderson","year":"2021","journal-title":"J Perinatol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.25338.1","article-title":"Recent advances in understanding and management of bronchopulmonary dysplasia","volume":"9","author":"Sahni","year":"2020","journal-title":"F1000Res"},{"key":"B28","doi-asserted-by":"publisher","first-page":"319","DOI":"10.5935\/0103-507X.20130054","article-title":"Ventilator-induced lung injury in preterm infants","volume":"25","author":"Carvalho","year":"2013","journal-title":"Rev Bras Ter Intensiva"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2025.1518957\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T05:30:17Z","timestamp":1745472617000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2025.1518957\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,24]]},"references-count":28,"alternative-id":["10.3389\/fped.2025.1518957"],"URL":"https:\/\/doi.org\/10.3389\/fped.2025.1518957","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,24]]},"article-number":"1518957"}}